Skip to content
HowShorted

Paratek Pharmaceuticals, Inc. short interest in 2022

In 2022, Paratek Pharmaceuticals, Inc.'s disclosed short interest ran from 7.49% of shares outstanding on 14 Jan 2022 to 6.26% on 30 Dec 2022, a change of -1.23 percentage points. The year's high was 11.33% on 14 Apr 2022 and its low 5.85% on 31 Oct 2022, averaging 8.16% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.72 days on 28 Feb 2022. Full history: Paratek Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Paratek Pharmaceuticals, Inc. in 2022

2022 in figures

Start of year
7.49% (14 Jan 2022)
End of year
6.26% (30 Dec 2022)
Change
-1.23 pp
High
11.33% (14 Apr 2022)
Low
5.85% (31 Oct 2022)
Average
8.16%
Highest days to cover
17.72 (28 Feb 2022)
SEC filings marked
4

Every report in 2022

Paratek Pharmaceuticals, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20227.49%14.47
31 Jan 20227.83%10.43
15 Feb 20228.42%11.91
28 Feb 20229.01%17.72
15 Mar 20229.71%16.7510-K filed
31 Mar 202210.71%10.43
14 Apr 202211.33%5.31
29 Apr 202211.15%11.09
13 May 202210.77%8.9510-Q filed
31 May 202210.22%17.38
15 Jun 20229.49%12.78
30 Jun 20227.44%2.71
15 Jul 20226.54%6.79
29 Jul 20227.65%14.68
15 Aug 20227.32%8.1710-Q filed
31 Aug 20227.30%16.12
15 Sep 20227.74%16.47
30 Sep 20228.24%10.34
14 Oct 20226.64%7.50
31 Oct 20225.85%10.40
15 Nov 20225.99%7.0610-Q filed
30 Nov 20226.42%9.76
15 Dec 20226.27%14.12
30 Dec 20226.26%6.03

See also: Paratek Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.